Denmark expects a winter free of COVID restrictions

Denmark will not implement COVID restrictions this winter, expects updated boosters to limit spread

Denmark is preparing to go through the coming winter without any coronavirus restrictions even with an expected rise in infections, Health Minister Magnus Heunicke said on Friday.

The Nordic country expects to be able to avoid lockdown measures due to new improved booster vaccines, greater immunity in the population and being able to better track the spread of the virus through measures such as waste-water testing.

"We are well prepared. The strategy and goal is a completely open society this coming winter," Heunicke told a press briefing.

EUROPE SET TO RECEIVE NEW OMICRON-RESISTANT COVID BOOSTER WITHIN DAYS OF APPROVAL

Denmark will receive 4.5 million doses in September of the COVID-19 booster vaccine updated to target the Omicron variant, with the first deliveries due to arrive next week, he said.

Although Denmark is slated to see an increase in COVID cases during this winter, a Danish health minister has revealed that the country will not institute more regulations. Pictured: A health care worker loads up a dose of the COVID vaccine for nursing home residents in Copenhagen, Denmark, on Jan. 23, 2021. (Ritzau Scanpix/Nils Meilvang via REUTERS/Files)

From Sept. 15 authorities will begin offering a fourth COVID-19 vaccine dose to those aged over 50 and vulnerable groups.

While Denmark saw a slight increase in COVID infections over the summer the number of cases now appears to be on the decline, Danish health authorities said.

The European Union's drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the Omicron variant, ahead of an anticipated rise in infections this winter.

WHAT YOU NEED TO KNOW ABOUT BA.5, THE VACCINE-RESISTANT VARIANT OF OMICRON

Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.

The European Medicines Agency is also expected to offer its opinion on adapted vaccines targeting the currently dominant BA.4/BA.5 variants in the coming weeks.

Load more..